Is SMC2 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
4/6
Valuation Score 4/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of SMC2 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: SMC2 (€30.98) is trading below our estimate of fair value (€435.64)
Significantly Below Fair Value: SMC2 is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for SMC2?
Key metric: As SMC2 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.
The above table shows the Price to Earnings ratio for SMC2. This is calculated by dividing SMC2's market cap by their current
earnings.
What is SMC2's PE Ratio?
PE Ratio
17x
Earnings
US$1.21b
Market Cap
US$20.54b
SMC2 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Price-To-Earnings vs Industry: SMC2 is good value based on its Price-To-Earnings Ratio (15.8x) compared to the Global Tech industry average (21.9x).
Price to Earnings Ratio vs Fair Ratio
What is SMC2's PE Ratio
compared to its
Fair PE Ratio?
This is the expected PE Ratio taking into
account the company's forecast earnings growth, profit margins
and other risk factors.
SMC2 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio
17x
Fair PE Ratio
n/a
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate SMC2's Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
The above table shows the analyst SMC2 forecast and predictions for the stock price in 12 month’s time.
Date
Share Price
Average 1Y Price Target
Dispersion
High
Low
1Y Actual price
Analysts
Current
€30.98
€38.30
+23.6%
50.8%
€88.34
€21.85
n/a
10
Nov ’25
€25.96
€57.81
+122.7%
38.7%
€92.28
€29.63
n/a
11
Oct ’25
€37.69
€67.68
+79.6%
42.5%
€117.44
€29.36
n/a
15
Sep ’25
n/a
€79.25
0%
39.5%
€135.44
€29.34
n/a
13
Aug ’25
n/a
€95.36
0%
27.5%
€138.41
€29.99
n/a
14
Jul ’25
n/a
€95.83
0%
28.1%
€139.23
€26.45
n/a
14
Jun ’25
n/a
€95.83
0%
28.1%
€139.23
€26.45
n/a
14
May ’25
n/a
€90.50
0%
32.7%
€140.30
€26.66
n/a
15
Apr ’25
n/a
€84.82
0%
35.6%
€124.55
€23.07
n/a
15
Mar ’25
n/a
€68.70
0%
34.2%
€119.81
€23.04
n/a
14
Feb ’25
n/a
€52.41
0%
22.3%
€64.56
€23.06
n/a
11
Jan ’25
n/a
€33.55
0%
26.0%
€45.87
€14.68
n/a
10
Dec ’24
n/a
€35.33
0%
21.2%
€47.08
€22.60
n/a
10
Nov ’24
n/a
€34.18
0%
20.4%
€47.10
€22.61
€25.96
10
Oct ’24
n/a
€34.08
0%
18.6%
€46.82
€23.41
€37.69
9
Sep ’24
n/a
€33.59
0%
19.1%
€45.56
€22.78
n/a
8
Aug ’24
n/a
€25.85
0%
43.7%
€36.05
€5.84
n/a
8
Jul ’24
n/a
€21.05
0%
52.7%
€36.49
€5.93
n/a
7
Jun ’24
n/a
€16.90
0%
60.5%
€37.20
€6.05
n/a
6
May ’24
n/a
€9.65
0%
37.9%
€16.05
€5.96
n/a
5
Apr ’24
n/a
€9.18
0%
39.3%
€15.93
€5.92
n/a
5
Mar ’24
n/a
€9.18
0%
39.3%
€15.93
€5.92
n/a
5
Feb ’24
n/a
€9.18
0%
39.3%
€15.93
€5.92
n/a
5
Jan ’24
n/a
€9.93
0%
37.8%
€16.79
€6.41
n/a
5
Dec ’23
n/a
€9.93
0%
37.8%
€16.79
€6.41
n/a
5
Nov ’23
n/a
€8.72
0%
35.8%
€13.89
€5.58
n/a
5
Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.